Advertisement

The impact of tumor location on the biological and oncological differences of colon cancer: Multi-institutional propensity score-matched study

      Highlights

      • Recurrence rates of stage I and II patients with left-sided colon cancer were higher than those in the right-sided group.
      • Recurrence free survival of LCC patients was significantly shorter than that of the RCC patients.
      • In stage III patients that experienced recurrence, CSS after recurrence of the RCC was significantly shorter than that of the LCC.

      Abstract

      Background

      Several studies have reported some differences between right-sided and left-sided colon cancer. The aim was to analyze the differences in clinical and pathological features, recurrence, and prognostic impact of tumor location in patients with tumors truly located in the right and left side of the colon.

      Patients

      The study included 6790 stage I-III colon cancer patients who underwent curative resection. Patient characteristics were balanced using propensity score matching.

      Results

      Recurrence rates of stage I and II patients with left-sided colon cancer were higher than those in the right-sided group, indicating that recurrence free survival of left-sided colon cancer patients was significantly shorter than that of the right-sided patients. In stage III patients that experienced recurrence, cancer specific survival after recurrence of the right-sided colon cancer patients was significantly shorter than that of the left-sided patients (P = 0.003).

      Conclusions

      In stage I-II patients, left-sided colon cancer was a significant risk factor for recurrence free survival, however, in stage III patients, right-sided colon cancer was a significant risk factor for after recurrence cancer specific survival.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and PersonalCorporate R&D Professionals
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hansen I.O.
        • Jess P.
        Possible better long-term survival in left versus right- sided colon cancer - a systematic review.
        Dan Med J. 2012; 59 (A4444)
        • Benedix F.
        • Kube R.
        • Meyer F.
        • Schmidt U.
        • Gastinger I.
        • Lippert H.
        Colon/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival.
        Dis Colon Rectum. 2010; 53: 57-64
        • Yahagi M.
        • Okabayashi K.
        • Hasegawa H.
        • et al.
        The worse prognosis of Right-sided compared with left-sided colon cancers: a systematic review and meta-analysis.
        J Gstrointest surg. 2016; 20: 648-655
        • Suttie S.A.
        • Shaikh I.
        • Mullen R.
        • Amin A.I.
        • Daniel T.
        • Yalamarthi S.
        Outcome of right-and left-sided colonic and rectal cancer following surgical resection.
        Colorectal Dis. 2011; 13: 884-889
        • Ishihara S.
        • Murono K.
        • Sasaki K.
        Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetrastatic colon cancers.
        Ann Surg. 2018 May; 267: 917-921
        • Warschkow Rene
        • Sulz Michael C.
        • Marti Lukas
        • et al.
        Better survival in right-sided versus left- sided stage I - III colon cancer patients.
        BMC Canc. 2016; 28: 554
        • Mik M.
        • Berut M.
        • Dziki L.
        • et al.
        Right- and left-sided colon cancer – clinical and pathological differences of the disease entity in one organ.
        Arch Med Sci. 2017; 13: 157-162
        • Gervaz P.
        • Bucher P.
        • Morel P.
        Two colons-two cancers: paradigm shift and clinical implications.
        J Surg Oncol. 2004; 88: 261
        • Cannon W.B.
        The movemrnts of the intestines studied by means of the Rontgen Rays.
        Am J Physiol. 1902; 6: 251-277
        • Ritchie J.A.
        Colonic Motor Activity and Bowel Function, Part I. Gut 9.
        1968: 442-456
        • Watanabe T.
        • Muro K.
        • Ajioka Y.
        • et al.
        Japanese society for cancer of colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.
        Int J Clin Oncol. 2018; 23: 1-34
        • Kanehara S.
        General Rules for Clinical and Pathological Studies on Cancer of the Colon and Anus. seventh ed. Kanehara & co, Tokyo2006
        • Edge S.
        • Byrd D.
        • Compton C.
        • Fritz A.
        • Greene F.
        • Trotti A.
        AJCC Cancer Staging Manual.
        seventh ed. Springer, New York2010
        • Iacopetta B.
        Are there two sides to colorectal cancer?.
        Int J Canc. 2002; 101: 403-408
        • Meguid R.A.
        • Slidell M.B.
        • Wolfgang C.L.
        • Chang D.C.
        • Ahuja N.
        Is there a difference in survival between right- versus left-sided colon cancers?.
        Ann Surg Oncol. 2008; 15: 2388-2394
        • Kerscher A.G.
        • Chua T.C.
        • Gasser M.
        • et al.
        Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patiets over two decades.
        Br J Canc. 2013; 108: 1432-1439
        • Klaver Y.L.
        • Simkens L.H.
        • Lemmens V.E.
        • et al.
        Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy.
        Eur J Surg Oncol. 2012; 38: 617-623
        • Moertel C.G.
        • Fleming T.R.
        • Macdonald J.S.
        • et al.
        Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
        N Engl J Med. 1990; 322: 352-358
        • Wolmark N.
        • Rockette H.
        • Fisher B.
        • et al.
        The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
        J Clin Oncol. 1993; 11: 1879-1887
        • Labianca R.
        • Nordlinger B.
        • Beretta G.D.
        • et al.
        Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. ESMO guidelines working group.
        Ann Oncol. 2010; 21: v70-77
        • The cancer genomic atlas network
        Comprehensive molecular characterization of fuman colon and rectal cancer.
        Nature. 2012; 487: 330-337
        • Tran B.
        • Kopetz S.
        • Tie J.
        • et al.
        Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastastatic colorectal cancer.
        Cancer. 2011; 117: 4623-4632
        • Lacopetta B.
        Are ther two sides to colorectal cancer?.
        Int J Canc. 2002; 101: 403-408
        • Breivilk J.
        • Lothe R.A.
        • Meling G.I.
        • Rognum T.O.
        • Borresen-Dale A.L.
        • Gaudernack G.
        Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors.
        Int J Canc. 1997; 74: 664-669
        • Clancy C.
        • Burke J.P.
        • Kalady M.F.
        • et al.
        BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis.
        Colorectal Dis. 2013; 15: e711-e718
        • Malesci A.
        • Laghi L.
        • Bianchi P.
        • et al.
        Reduced likelihood of metastases in patients with microsatellite unstable olorectal cancer.
        Clin Canc Res. 2007; 13: 3831-3839
        • Popat S.
        • Hubner R.
        • Houlston R.S.
        Systematic review of microsatellite instability and colorectal cancer prognosis.
        J Clin Oncol. 2005; 23: 609-618
        • Jernvall P.
        • makinen M.J.
        • Karttunen T.J.
        • Makela J.
        • Vihko P.
        Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancer.
        Eur J Canc. 1999; 35: 197-201
        • Phipps Amanda I.
        • Lindor Noralane M.
        • Jenkins Mark A.
        • et al.
        Colon and rectal survival by tumor location and microsatellite instability: the colon cancer family registry.
        Dis Colon Rectum. 2013; 56 (8): 937-944
        • Gervaz P.
        • Cerottini J.P.
        • Bouzourene H.
        • et al.
        A comparison of chromosomal instability and microsatellite instability sa predictors of survival in T3N0 colorectal cancer patients.
        Surgery (St Louis). 2002; 131: 190-197
        • Weiss J.M.
        • Pfau P.R.
        • O'Connor E.S.
        • et al.
        Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results—medicare data.
        J Clin Oncol. 2011; 29: 4401-4409
        • Sinicrope F.A.
        • Mahoney M.R.
        • Smyrk T.C.
        • et al.
        Prognnostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX- based adjuvant chemotherapy.
        J Clin Oncol. 2013; 31: 3664-3672
        • Stintzing S.
        • Tejpar S.
        • Gibbs P.
        • et al.
        Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes.
        Eur J Canc. October 2017; 84: 69-80
        • Shen H.
        • Yang J.
        • Huang Q.
        • et al.
        Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
        World J Gastroenterol. 2015; 21 (6470e8)